Key takeaways: Foundayo UK approval 2026
- MHRA approval: Foundayo (orforglipron) was approved by the MHRA in August 2026 for weight management and type 2 diabetes.
- Daily tablet: Unlike most current GLP-1 treatments, Foundayo is a once-daily tablet rather than a weekly injection.
- Flexible routine: It can be taken at any time of day without the strict food or water restrictions associated with the Wegovy Pill.
- Typical eligibility: Prescription weight loss medicines are typically considered for adults with a BMI of 30 or above, or 27 with weight-related health conditions.
- Waitlist at PrivateDoc: Foundayo is not yet in stock. Join the waiting list and we will email you when we can prescribe and dispense following a clinical assessment.
What is Foundayo (orforglipron) and how does it work?
Foundayo (orforglipron) is a once-daily oral weight loss pill approved by the MHRA in August 2026. It is a small-molecule, non-peptide GLP-1 receptor agonist. That means it mimics a natural gut hormone involved in appetite regulation, helping you feel fuller sooner, eat smaller portions, and support weight management alongside diet and physical activity.
As a non-peptide molecule, orforglipron is designed to be absorbed as a tablet without the empty-stomach routine required for oral semaglutide. Clinical trials have shown meaningful weight reduction, which means effective medical weight management online does not have to rely exclusively on injectable treatments.
Read more on the Foundayo treatment page, including how it is taken, side effects, and how it compares with other GLP-1 options.
How is Foundayo different from Wegovy and Mounjaro?
Unlike Wegovy and Mounjaro, which are weekly injections, Foundayo is taken as a daily tablet. The Wegovy Pill is also a daily tablet, but it contains semaglutide and must be taken on an empty stomach with a small amount of plain water. Foundayo can be taken at any time of day, with or without food.
These medicines are not interchangeable. Your clinician will consider your medical history, preferences, and treatment goals before recommending an option. Foundayo is currently waitlist only through PrivateDoc, while Wegovy, the Wegovy Pill, and Mounjaro can be prescribed today after a successful clinical assessment.
| Medication |
Active ingredient |
Format |
Frequency |
Key convenience factor |
| Foundayo |
Orforglipron |
Tablet |
Once daily |
No food or water restrictions |
| Wegovy |
Semaglutide |
Injection |
Once weekly |
Only one dose per week |
| Wegovy Pill |
Semaglutide |
Tablet |
Once daily |
Requires strict morning fasting |
| Mounjaro |
Tirzepatide |
Injection |
Once weekly |
Targets two hormone receptors (GIP and GLP-1) |
Who is eligible for the Foundayo weight loss pill in the UK?
The MHRA has licensed Foundayo for adults with a body mass index (BMI) of 30 or above. It is also approved for adults with a BMI of 27 or above who have at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes.
Meeting these BMI thresholds does not automatically mean the medicine is right for you. A UK-registered prescriber will also review your medical history to screen for contraindications. For example, certain endocrine disorders or a history of pancreatitis may mean that GLP-1 medicines are not the safest choice for your health profile.
If you want treatment that is available now, you can still compare current weight loss treatments and complete a consultation for Wegovy, the Wegovy Pill, or Mounjaro.
How to get prescription weight loss medication online safely
A safe online clinic requires a comprehensive medical questionnaire reviewed by a qualified prescriber. At PrivateDoc, GMC-registered doctors evaluate your health history before issuing any prescription. Medicines are then dispensed and delivered discreetly through a GPhC-registered UK pharmacy partner.
You can confirm how the service is regulated on our regulations page, and see how PrivateDoc works from consultation through to delivery.
Foundayo is currently waitlist only. Joining the list does not start a purchase or a consultation. When stock is available, we will contact you so you can complete a clinical assessment if you still wish to proceed.
Your next steps toward better health
Deciding to seek medical support for weight loss is a significant and positive step. Foundayo provides another option, particularly if you have been hesitant about injectable treatments. Pricing and availability through PrivateDoc are still to be confirmed.
A consultation does not commit you to a specific medicine. It opens a dialogue with a qualified clinician who can guide you toward the safest and most effective choices for your circumstances. If you are interested in Foundayo specifically, join the waiting list. If you would rather start a treatment we can prescribe today, begin with a weight loss consultation.
Disclaimer: This article is for general information only and does not replace personalised medical advice. A prescription will only be issued following a successful clinical assessment once Foundayo is available through PrivateDoc.
